Parmax Pharma Limited - Charges

Every charge - open or closed - that lenders have registered against Parmax Pharma Limited, with the most recent activity at the top.

1994-11-02 Hadamtala, Gujarat Active Listed Active Compliant
Share
PP Parmax Pharma Limited
Open charges
1
8.40 cr
Closed charges
4
14.96 cr
Total
5
23.36 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 2 15.12 cr
2 Hdfc Bank Limited 3 8.24 cr
All charges (5) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101092470 Others 17 Apr 2025 - - 8.40 cr Open
100775935 Others 31 May 2023 10 Nov 2023 07 Apr 2025 6.72 cr Closed
100240259 Hdfc Bank Limited 08 Feb 2019 - 16 Oct 2023 1.12 cr Closed
100215130 Hdfc Bank Limited 16 Oct 2018 14 Sep 2021 16 Oct 2023 6.85 cr Closed
100172862 Hdfc Bank Limited 28 Jul 2017 - 12 May 2019 26.70 Lakh Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Parmax Pharma Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Parmax Pharma Limited (CIN: L24231GJ1994PLC023504). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Parmax Pharma Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.